Hochschulschrift
Discovery and optimization of 1,3,5-trisubstituted pyrazolines as potent and highly selective allosteric inhibitors of PKCzeta
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Saarbrücken, Universität des Saarlandes, Diss., 2013
- Schlagwort
-
Allgemeine Entzündungsreaktion ; Tumorsuppressor-Gen ; Zellwachstum
Arzneimittelentwicklung
Arzneimitteldesign
- Ereignis
-
Veröffentlichung
- (wo)
-
Saarbrücken
- (wer)
-
Saarländische Universitäts- und Landesbibliothek
- (wann)
-
2013
- Urheber
-
Abdel-Latif, Mohammad Abdel-Halim Abdel-Naby
- Beteiligte Personen und Organisationen
-
Hartmann, Rolf W.
- URN
-
urn:nbn:de:bsz:291-scidok-54785
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Abdel-Latif, Mohammad Abdel-Halim Abdel-Naby
- Hartmann, Rolf W.
- Saarländische Universitäts- und Landesbibliothek
Entstanden
- 2013
Ähnliche Objekte (12)
Highly potent, selective acylguanidine type histamine H2-receptor agonists : synthesis and structure-activity relationships
EGFR binding Fc domain-drug conjugates: stable and highly potent cytotoxic molecules mediate selective cell killing
Design and synthesis of highly potent and selective pseudokinase inhibitors targeting calcium/calmodulin-dependent serine protein kinase
Potent and selective ABCG2 inhibitors derived from tariquidar
Potent and selective ABCG2 inhibitors derived from tariquidar
Development of potent and selective dopamine D3 receptor ligands
Lead optimization of highly potent and selective CYP11B1 inhibitors for the treatment of Cushing’s syndrome and chronic wounds
Highly potent and selective acylguanidine-type histamine H2 receptor agonists: synthesis and structure-activity relationships of mono- and bivalent ligands
Highly Selective Broadband mm-Wave Diplexer Design
Anthraniloyl-derived nucleotides as potent and selective adenylyl cyclase inhibitors
Affordability of highly selective colleges and universities II
Inhibition of 17β-HSD1: SAR of bicyclic substituted hydroxyphenylmethanones and discovery of highly potent inhibitors enabling a proof of principle study in rodents
Highly potent, selective acylguanidine type histamine H2-receptor agonists : synthesis and structure-activity relationships
EGFR binding Fc domain-drug conjugates: stable and highly potent cytotoxic molecules mediate selective cell killing
Design and synthesis of highly potent and selective pseudokinase inhibitors targeting calcium/calmodulin-dependent serine protein kinase
Potent and selective ABCG2 inhibitors derived from tariquidar
Potent and selective ABCG2 inhibitors derived from tariquidar
Development of potent and selective dopamine D3 receptor ligands
Lead optimization of highly potent and selective CYP11B1 inhibitors for the treatment of Cushing’s syndrome and chronic wounds
Highly potent and selective acylguanidine-type histamine H2 receptor agonists: synthesis and structure-activity relationships of mono- and bivalent ligands
Highly Selective Broadband mm-Wave Diplexer Design
Anthraniloyl-derived nucleotides as potent and selective adenylyl cyclase inhibitors
Affordability of highly selective colleges and universities II
Inhibition of 17β-HSD1: SAR of bicyclic substituted hydroxyphenylmethanones and discovery of highly potent inhibitors enabling a proof of principle study in rodents
Highly potent, selective acylguanidine type histamine H2-receptor agonists : synthesis and structure-activity relationships
EGFR binding Fc domain-drug conjugates: stable and highly potent cytotoxic molecules mediate selective cell killing
Design and synthesis of highly potent and selective pseudokinase inhibitors targeting calcium/calmodulin-dependent serine protein kinase
Potent and selective ABCG2 inhibitors derived from tariquidar
Potent and selective ABCG2 inhibitors derived from tariquidar
Development of potent and selective dopamine D3 receptor ligands
Lead optimization of highly potent and selective CYP11B1 inhibitors for the treatment of Cushing’s syndrome and chronic wounds
Highly potent and selective acylguanidine-type histamine H2 receptor agonists: synthesis and structure-activity relationships of mono- and bivalent ligands
Highly Selective Broadband mm-Wave Diplexer Design
Anthraniloyl-derived nucleotides as potent and selective adenylyl cyclase inhibitors
Affordability of highly selective colleges and universities II